Frontiers | Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease
Discovery of the Diphenyl 6-Oxo-1,6-dihydropyridazine-3-carboxylate/carboxamide Analogue J27 for the Treatment of Acute Lung Injury and Sepsis by Targeting JNK2 and Inhibiting the JNK2-NF-κB/MAPK Pathway | Journal of Medicinal Chemistry,Microglia and Astrocytes in Alzheimer's Disease in the Context of the Aberrant Copper Homeostasis Hypothesis,Frontiers | Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease,March 23, 2024 Dairy Star - 3rd Section by Dairy Star - Issuu